These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24525731)

  • 1. TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.
    Xu W; Wang S; Chen Q; Zhang Y; Ni P; Wu X; Zhang J; Qiang F; Li A; Røe OD; Xu S; Wang M; Zhang R; Zhou J
    Cell Death Dis; 2014 Feb; 5(2):e1055. PubMed ID: 24525731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines.
    Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J
    Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
    Xu W; Chen Q; Wang Q; Sun Y; Wang S; Li A; Xu S; Røe OD; Wang M; Zhang R; Yang L; Zhou J
    Cell Death Dis; 2014 Dec; 5(12):e1551. PubMed ID: 25476899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DNA Repair and Drug Transporter in Relation to Chemosensitivity in Primary Culture of Thai Gastric Cancer Patients.
    Wongsirisin P; Limpakan Yamada S; Yodkeeree S; Punfa W; Limtrakul P
    Biol Pharm Bull; 2018; 41(3):360-367. PubMed ID: 29491212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance.
    Park SY; Lam W; Cheng YC
    Cancer Res; 2002 Jan; 62(2):459-65. PubMed ID: 11809696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEITC reverse multi-drug resistance of human gastric cancer SGC7901/DDP cell line.
    Tang T; Song X; Liu YF; Wang WY
    Cell Biol Int; 2014 Apr; 38(4):502-10. PubMed ID: 23956061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
    Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
    Fu D; Wang C; Yu L; Yu R
    Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines.
    Li W; Jie Z; Li Z; Liu Y; Gan Q; Mao Y; Wang X
    Mol Med Rep; 2014 Jun; 9(6):2423-8. PubMed ID: 24699918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 confers acquired cisplatin resistance in breast cancer cells.
    Kwok JM; Peck B; Monteiro LJ; Schwenen HD; Millour J; Coombes RC; Myatt SS; Lam EW
    Mol Cancer Res; 2010 Jan; 8(1):24-34. PubMed ID: 20068070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer.
    Yousafzai NA; Zhou Q; Xu W; Shi Q; Xu J; Feng L; Chen H; Shin VY; Jin H; Wang X
    Cell Death Dis; 2019 May; 10(5):363. PubMed ID: 31043584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
    Tung CL; Jian YJ; Chen JC; Wang TJ; Chen WC; Zheng HY; Chang PY; Liao KS; Lin YW
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):657-66. PubMed ID: 27026405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair.
    Kudo K; Gavin E; Das S; Amable L; Shevde LA; Reed E
    Oncogene; 2012 Nov; 31(44):4718-24. PubMed ID: 22266871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
    Li M; Zhang YY; Shang J; Xu YD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib enhanced the cytotoxic effect of cisplatin in drug-resistant human gastric cancer cells by inhibition of cyclooxygenase-2.
    Xu HB; Shen FM; Lv QZ
    Eur J Pharmacol; 2015 Dec; 769():1-7. PubMed ID: 26407653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF138 confers cisplatin resistance in gastric cancer cells via activating Chk1 signaling pathway.
    Lu Y; Han D; Liu W; Huang R; Ou J; Chen X; Zhang X; Wang X; Li S; Wang L; Liu C; Miao S; Wang L; Ma C; Song W
    Cancer Biol Ther; 2018; 19(12):1128-1138. PubMed ID: 30260263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
    Yan LH; Wang XT; Yang J; Lian C; Kong FB; Wei WY; Luo W; Xiao Q; Xie YB
    World J Gastroenterol; 2013 Jul; 19(26):4155-65. PubMed ID: 23864778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P; Li J; Jiang HG; Lan T; Chen YC
    Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatin-induced apoptosis.
    Xu HY; Chen ZW; Pan YM; Fan L; Guan J; Lu YY
    Dig Dis Sci; 2012 Jul; 57(7):1847-56. PubMed ID: 22359193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.